Oxeia Biopharmaceuticals

View Original

Pharmaceutical Technology: A tough puzzle: complexity slows drug development for concussions

Condition heterogeneity warrants multiple therapeutic approaches, but past failures highlight developmental challenges.

Adam Zamecnik September 12, 2022